Compumedics Limited (ASX:CMP)

Australia flag Australia · Delayed Price · Currency is AUD
0.305
+0.005 (1.67%)
At close: Mar 6, 2026
19.61%
Market Cap 60.93M
Revenue (ttm) 58.49M
Net Income (ttm) 113.00K
Shares Out 199.76M
EPS (ttm) 0.00
PE Ratio 539.18
Forward PE 20.33
Dividend n/a
Ex-Dividend Date n/a
Volume 220,188
Average Volume 54,566
Open 0.300
Previous Close 0.300
Day's Range 0.300 - 0.305
52-Week Range 0.240 - 0.450
Beta 0.21
RSI 37.23
Earnings Date Feb 22, 2026

About Compumedics

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory stud... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1987
Employees 175
Stock Exchange Australian Securities Exchange
Ticker Symbol CMP
Full Company Profile

Financial Performance

In fiscal year 2025, Compumedics's revenue was 51.04 million, an increase of 1.55% compared to the previous year's 50.26 million. Losses were -1.27 million, 275.1% more than in 2024.

Financial Statements

News

There is no news available yet.